Tetrahydrocannabinol drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| marijuana | associated_with | Tetrahydrocannabinol | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Genetics of substance use disorders in the era of big data. (2021)
- Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure. (2015)
- Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. (2014)
- The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- Gabapentin treatment for alcohol dependence: a randomized clinical trial. (2014)
- The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
- Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. (1998)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tetrahydrocannabinol | drug | 9 | 12 |